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Background: Studies have shown that ischemia-reperfusion (I/R) produces free radicals leading to lipid
peroxidation and damage to skeletal muscle. The purposes of this study were 1) to assess the histological findings
of gastrocnemius muscle (GC) and tibialis anterior muscle (TA) in I/R injury model mice, 2) to histologically analyze
whether a single pretreatment of edaravone inhibits I/R injury to skeletal muscle in murine models and 3) to
evaluate the effect of oxidative stress on these muscles.
Methods: C57BL6 mice were divided in two groups, with one group receiving 3 mg/kg intraperitoneal injections of
edaravone (I/R + Ed group) and the other group receiving an identical amount of saline (I/R group) 30 minutes
before ischemia. Edaravone (3-methy-1-pheny1-2-pyrazolin-5-one) is a potent and novel synthetic scavenger of free
radicals. This drug inhibits both nonenzymatic lipid peroxidation and the lipoxygenase pathway, in addition to
having potent antioxidant effects against ischemia reperfusion. The duration of the ischemia was 1.5 hours, with
reperfusion at either 24 or 72 hours (3 days). Specimens of gastrocnemius (GC) and anterior tibialis (TA) were
removed for histological evaluation and biochemical analysis.
Results: This model of I/R injury was highly reproducible in histologic muscle damage. In the histologic damage
score, the mean muscle fibers and inflammatory cell infiltration in the I/R + Ed group were significantly less than
the corresponding values of observed in the I/R group. Thus, pretreatment with edaravone was observed to have a
protective effect on muscle damage after a period of I/R in mice. In addition, the mean muscle injury score in the
I/R + Ed group was also significantly less than the I/R group. In the I/R + Ed group, the mean malondialdehyde
(MDA) level was lower than in the I/R group and western-blotting revealed that edaravone pretreatment decreased
the level of inducible nitric oxide synthase (iNOS) expression.
Conclusions: Edaravone was found to have a protective effect against I/R injury by directly inhibiting lipid
peroxidation of the myocyte by free radicals in skeletal muscles and may also reduce the secondary edema and
inflammatory infiltration incidence of oxidative stress on tissue.
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Ischemia-reperfusion (I/R) injury refers to tissue damage
caused when blood returns to a tissue after a period of
ischemia [1]. Reperfusion triggers a cascade of acute
inflammatory events, leading to cellular death and resul-
ting in tissue dysfunction and necrosis [1]. Most research
concerning I/R injury has focused on the heart, kidney,
liver, brain, lung and intestines since these tissues are con-
sidered vital organs [2-4]. I/R injury to skeletal muscles is
also a serious problem however, and can cause local dis-
turbances as well as systemic problems such as crush syn-
drome due to leakage from muscle cells into circulating
blood. I/R injuries of skeletal muscles are commonly seen
in a variety of trauma and other injuries including muscle
damage, transplantations, plastic surgery and limb surgery
with extended tourniquet application [5-7].
Although the pathophysiology of I/R injuries has not
been fully elucidated due to complex interactions of in-
flammatory and immunologic signaling pathways [8], it
is clear that accumulated free radicals and anaerobic me-
tabolites during ischemia cause the migration of white
blood cells and the release of inflammatory factors such
as interleukin and free radicals in the reperfusion phase
[9-13]. These compounds eventually damage muscle tis-
sues, resulting in irrecoverable muscle damage and gen-
eral complications [14-16]. One of the strategies of
treatment for I/R injury likely to be considered is sca-
venging free radicals, because I/R injury can activate
pathways generating reactive oxygen species with the
ability to break down cell membranes [14,17]. In fact,
there have been several reports in which a scavenger of
free radicals was effective in reducing I/R injuries. Elmali
et al. stated that resveratrol, which was previously shown
to have free radical scavenging and antioxidant proper-
ties in various tissues, protected the skeletal muscles
against I/R injuries [18]. Ozyurt et al. described how
caffeic acid phenethyl ester (CAPE) protected skeletal
muscles from reperfusion injury, and how this protective
effect can probably be ascribed to CAPE’s free radical
scavenging activity [19].
Edaravone (3-methy-1-pheny1-2-pyrazolin-5-one) is a
potent and novel synthetic scavenger of free radicals. This
drug inhibits both nonenzymatic lipid peroxidation and the
lipoxygenase pathway, in addition to having potent antioxi-
dant effects against ischemia reperfusion-induced vas-
cular endothelial cell injury, delayed neuronal death, brain
edema, and concomitant neurological deficits [20-23]. In
Japan, edaravone was approved in 2002 for use in treating
acute brain infarctions and has been reported to have anti-
stroke neuro-protective effects [20-23]. Therefore, we hy-
pothesized that edaravone could protect skeletal muscles
from I/R injury in an in vivo model.
The purposes of this study were 1) to assess the histo-
logical findings of gastrocnemius muscle (GC) withmany slow fibers and tibialis anterior muscles (TA) with
many fast fibers in using the Crawford model of I/R
injury [5], 2) to histologically analyze whether a single
pretreatment of edaravone inhibits I/R injury on skeletal
muscle in these mouse models, and 3) to evaluate the
effect of oxidative stress on these muscles.
Methods
Subjects
Forty C57BL6 mice (8-10 w, male, 22-28 g; SLC, Hamama-
tsu, Japan) were used in all experiments of this study. The
animals were housed in a temperature-controlled environ-
ment and maintained on a 12 hour light–dark cycle with
food and water available ad libitum. The experimental proto-
col was approved by the committee of animal research at
Mie University.
Animal models
Animals were deeply anesthetized with an intraperito-
neal injection of pentobarbital sodium (0.05 mg/g body
weight). Bands were applied to the left proximal thighs
of 40 animals by 4.5 oz orthodontic rubber bands (ORB;
American Orthodontics, Sheboygan, WI) as described
by Crawford et al. [5]. Intraperitoneal injection of
edaravone 3 mg/kg (I/R + Ed group) or injection of the
same amount of saline (I/R group) was administered
30 minutes before rubber band application. The period
of the ischemia was 1.5 hours, and the rubber band was
released and specimens were collected with reperfusion
at either 24 hours (n=10 in each group) or 72 hours
(n=10 in each group). Mice remained anesthetized
throughout the duration of ischemia with supplemental
anesthesia (pentobarbital sodium) as needed. Then,
reperfusion was performed by cutting the band with
scissor. Specimens of gastrocnemius (GC), and anterior
tibialis (TA) were removed. Under deep anesthesia mice
were pinned and using a microscope, muscles were care-
fully excised. The wet weight of the resected muscles
was measured.
Drug administration methods
Edaravone was provided by Mitsubishi Tanabe Pharma
Corporation (Tokyo, Japan). It was dissolved in 1N NaOH
that was titrated to pH 7.4 with 1N HCL to prepare a final
concentration of 0.3 mg/ml. Finally, edaravone was injec-
ted intraperitoneally at 3 mg/kg. Intraperitoneal injection
of the same amount of saline (I/R group) was adminis-
tered. The application of drugs was performed under the
deep anesthesia before the ischemia by the tourniquet.
Histological analysis
The ten GC and TA samples (n=5 in each group 24 h,
72 h) harvested from each group were immediately fixed
in 4% paraformaldehyde and stored at 4°C overnight.
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microtome and stained with hematoxylin and eosin
(HE). After dewaxing in xylene and rehydration in
graded methanol (99% to 70% (v/v)) followed by distilled
water, HE staining was performed. The stained slides
were examined at 200× magnification on microscopes
equipped with a digital camera (BX50; Olympus, Tokyo,
Japan). Using a standardized method, each muscle was
divided into 15 fields for GC samples and 10 fields for
TA samples that were photographed using a CoolSNAP
color camera (Roper Scientific, Tuscan, AZ, USA) and
analyzed with the software program RS Image (Roper
Scientific).
Histologic grading
In tissue sections stained with HE, a histological damage
score was assigned on the following scales: disorganization
and degeneration of the muscle fibers (0: Normal, 1: Mild,
2: Moderate, 3: Severe); Inflammatory cell infiltration
(0: Normal, 1: Mild, 2: Moderate, 3: Severe) [24]. To test
for reproducibility we reviewed our grading with 2 ad-
ditional laboratory members unaware of the experimental
design.
Histologic injury severity score for muscles
The absolute injury score of each muscle was deter-
mined by a method similar to McCormack et al. [25].
Every myocyte in all 15 (GC) or 10 (TA) photograph
fields was scored. The muscle injury score was expressed
as a percentage, obtained by the number of injured
myocytes divided by the total number of myocytes
scored within the all fields. The intraobserver and
interobserver reliability correlation coefficients of muscle
injuries at 2 times were excellent (K= 0.98, 0.90, respec-
tively), as determined by the Cohen kappa correlation
coefficient.
Measurement of malondialdehyde (MDA)
MDA is one of the end products of lipid peroxidation, and
has been widely used to determine lipid peroxidation levels
[26,27]. The lipid peroxidation was assessed by measuring
the MDA content of tissue using a thiobarbituric acid
(TBA) assay kit (Northwest Life Science Specialties LLC,
Vancouver, WA, USA). The harvested muscle (n=5 in each
group 24 h) were immediately frozen in liquid nitrogen
after washing with 0.9% NaCl. These resected muscles
were then homogenized using a Cryopress (Microtech,
Chiba, Japan)、 and stirred in an assay buffer (phosphate
buffer, pH 7.0 with EDTA) for 1 hour. Butanol was then
added to the sample to remove hemoglobin, because
malondialdehyde (MDA) or MDA-like substances and TBA
can react, producing a pink pigment in the TBA test reaction.
The precipitate was centrifugally pelleted (3 minutes at10,000 g), and an aliquot of the supernatant was reacted with
an equal volume of TBA at 60°C for 60 min. After cooling,
sample absorbance at 540 nm was measured. The results
were expressed in nmol /mg protein for tissue samples, using
the standard graphic prepared according to the measurements
done with a standard solution. (Solutions 0 to 4)
Western blotting
Inducible nitric oxide synthase (iNOS) is a messenger
protein involved in immune response, which produces
large amounts of NO [28,29]. Expression of iNOS was
analyzed by western blotting. Harvested muscle (n=5 in
each group 24 h) were frozen in liquid nitrogen, homog-
enized using a Cryopress (Microtech, Chiba, Japan) and
stirred in the RIPA buffer (10 mMTrisHCl (PH 7.4), 1%
NP40, 0.1% Sodium deoxycolate, 0.1% Sodium dodecyl
sulfate (SDS), 0.15M NaCl, 1mM EDTA, 10 ug/ml apro-
tinine) for 1 hour. The supernatants were separated by
Sodium dodecyl sulfate Polyacrylamide gel electrophoresis
(SDS–PAGE), transferred to nitrocellulose membranes,
and immunoblotted with primary antibodies. The primary
antibody was polyclonal rabbit antiserum against iNOS
(Affinity BioReagents, Golden, CO, USA). The bands were
visualized using the ECL Western blotting detection sys-
tem (GE Healthcare UK Ltd., Buckinghamshire, England)
and were detected by an LAS-4000 imager (Fujifilm,
Tokyo, Japan).
Statistical analysis
Stat View 5.0 for Windows (SAS Institute, NC, USA)
was used for statistical analysis. Data were analyzed
using the Mann–Whitney U-test or by calculating
Spearman’s coefficient of rank correlation. Values of
p<0.05 were deemed statistically significant.
Results
The degree of muscle injuries in Crawford models was
highly reproducible with few histological differences
between subjects
None of the animals died and none required respiratory
support or life support medication during experimental
procedures in the 1.5 h model for this study. Histologi-
cally, uninjured muscle fibers were characterized as having
well defined borders, consistent texture, and uniformity
throughout the muscle fiber without holes or breaks. On
the other hand, both GC and TA muscles in the I/R group
exhibited destruction of muscle fibers with edema and in-
flammatory cell infiltration 24 hours after reperfusion. In
addition, these findings were more pronounced 3 days
after reperfusion (Figure 1A,B). Disorganization of muscle
fibers and inflammatory cell infiltration was more severe
in the center of muscles compared to in the periphery.
Figure 1 Histological analysis 72hours (3days) after reperfusion in GC samples. (A) I/R group: muscle tissue had areas of gross focal and
regional fiber necrosis and degeneration, marked cellular infiltration, and loss of tissue structure. (B) I/R + Ed group: less muscle damages and
uniform distribution comparison to the I/R group.
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nous Thrombosis (DVT) observed. The degree of injuries
was largely uniform in most subjects, and all subjects had a
high histologic damage score 3 days after I/R injury. This
model of I/R injury was highly reproducible in histologic
muscle damage just as in the study by Crawford et al. [5].Application of edaravone significantly inhibited I/R injury
of skeletal muscles in histological analysis
In contrast to the muscle tissues observed after I/R injury
in the I/R group (Figure 1A), damage to muscle fibers was
rarely observed in the I/R + Ed group. There were how-
ever some cases of inflammatory cell infiltration and
edema between muscle fibers (Figure 1B). In the histologic
damage score, the muscle fibers and inflammatory cell in-
filtration in the I/R + Ed group were 2.31 ± 0.569 for GC
and 2.22 ± 0.465 for TA, both of which were significantly
less than the corresponding values of 5.55 ± 0.501 (GC)
and 4.92 ± 0.853 (TA) observed in the I/R group.
(P<0.001) (Figure 2A) Thus, pretreatment with edaravone
was observed to have a protective effect on muscle damage
after a period of I/R in mice. In addition, the mean muscle
injury score in the I/R + Ed group was 11.1% (116/1051)
in GC and 9.1% (83/903) in TA, also significantly less than
the 33.4% (363/1085) and 20.9% (193/923) seen in the I/R
group. (P<0.001) The difference was also present 3 days
after reperfusion, in which application of edaravone
inhibited muscle damage from the 33.7% (394/1179) in
GC and 19.7% (192/947) in TA seen in the I/R group to
7.9% (93/1178) and 6.5% (62/957). (P<0.001) (Figure 2B)
Histological findings indicate that the scavenging of free
radicals by edaravone may inhibit inflammatory cascades.
(Figure 3A,B)The scavenging of free radicals by edaravone not only
directly inhibited I/R injury to skeletal muscles but also
protected myocytes via indirect transduction of oxidative
stress
The extent of lipid peroxidation was determined by MDA
analysis in the I/R affected muscles. The mean MDA level
in the muscle tissues of the I/R group was 1.8 nmol/mg
protein in GC and 2.6 nmol/mg protein in TA whereas it
was 0.9 nmol/mg protein in GC and 0.7 nmol/mg protein
in TA of the I/R + Ed group. (Figure 4) There was a ten-
dency towards lower peroxidation levels observed in the
GC samples of the I/R + Ed group, but it was not statisti-
cally significant. (p = 0.08) The difference in the TA pero-
xidation levels however was significantly lower in the I/R +
Ed group. (p<0.05) In addition, western-blotting revealed
that pretreatment of edaravone decreased the level of
iNOS expression. (Figure 5) This result suggests that sca-
venging of free radicals could inhibit the injuries caused by
oxidative stress to myocytes [30].
Discussion
I/R injuries are defined as the paradoxical exacerbation
of cellular dysfunction and death following the resto-
ration of blood flow to previously ischemic tissues [1].
Re-establishment of blood flow is essential to salvage is-
chemic tissues; however reperfusion itself causes further
damage to the ischemic tissue, threatening function and
viability of the organ. I/R injuries occur in a wide range
of organs including the heart, kidney, liver, brain and in-
testines heart, liver, brain, kidney, colon and skeletal
muscles [2-4,31]. Examples of I/R injuries of skeletal
muscles in this study can arise as a consequence of a
range of vascular events including thrombolytic therapy,
organ transplantation, limb trauma, or aortic clamping
Figure 2 Histological grading and Histological injury severity score 72hours (3days) after reperfusion. (A) I/R + Ed group histological
damage score was significantly less than in the I/R group. (P<0.001) (B) Histological injury severity score expressed as percent injured myocytes,
showed statistical difference between the I/R and I/R + Ed groups in both GC and TA samples. (P<0.001).
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sulting tissue destruction and edema can lead to further
worsening of the physiology and increased microvessel
constriction leading to compartment syndrome [32-34]. In
addition, if a large volume of tissue falls into ischemia,
subsequent revascularization and hence reperfusion of the
ischemic tissue will also induce systemic effects on distant
organs, leading to a multi-system organ failure called
crush syndrome [35,36]. Effective therapies counteracting
these complications are not yet available in clinical set-
tings, though there have been a number of reports regar-
ding treatment for I/R injuries of skeletal muscles [37-39].
Despite such studies devoted to examining I/R injury
of skeletal muscle and its underlying mechanisms, no
universally accepted model for inducing skeletal muscle
I/R injury has evolved. The Crawford model was used
for the tourniquet-induced hindlimb I/R injury in this
study [5]. Another model put forth by McGivney, using
a hemorrhoidal ligator (MHL) band has been widelyFigure 3 Histological assessment percentage injury over time. (A) GC
percentage at 24h, and continuously decreased injury rate at 72h. (P<0.001
lower injury percentage and a decreasing injury rate at the 72h sample timused as tourniquet-induced hindlimb I/R injury model
in mice [37]. The MHL model, however, has been criti-
cized for its inability to control for nonspecific neuro-
muscular damage due to the crushing force of the
rubber band on the underlying tissue. Additionally, the
tension gradually decreases in this band. On the other
hand, the model using an orthodontic rubber band
(ORB) reported by Crawford appears to be superior to
the MHL band model because ORBs produce complete,
consistent, and reproducible ischemia in murine models
of I/R using significantly less tension than the MHL
band. Our histological analysis also showed that there
was little difference in the degree of injury of muscle fi-
bers, indicating that this simple model was likely to be
suitable for evaluation of the effects of treatment for
skeletal muscles of I/R injury.
While there have been several clinical strategies de-
signed to reduce the effects of I/R injuries, none of them
have been broadly successful in attenuating detrimentalsamples: The I/R + Ed group showed a significantly a lower injury
) (B) TA samples: The I/R + Ed group similary showed significantly a
e. (P<0.001).
Figure 4 Malondialdehyde (MDA) concentration in GC and TA 24hours (1day) after reperfusion. The I/R + Ed group, the mean MDA level
was lower than in the I/R group. There was a tendency towards lower peroxidation levels observed in the GC samples of the I/R + Ed group, but
it was not statistically significant. (p = 0.08) The difference in the TA peroxidation levels however was significantly lower in the I/R + Ed
group. (p<0.05).
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tion, hyperbaric oxygen, hypothermia, and pre- and post-
injury conditioning [38-40]. The potential therapeutic
benefits of edaravone has been previously recognized and
investigated for I/R injuries such as cerebral infarctions as
there have been a number of reports that oxygen free ra-
dicals are involved in the pathogenesis of I/R injury
[20,22,41]. A recent Japanese multicenter randomized
clinical trial has demonstrated that edaravone, adminis-
tered within 72 hours after onset of ischemic stroke sig-
nificantly reduces brain infarct volume and produces
sustained benefits in the functional outcomes of patients
compared with placebo treatment [23]. These results led
to our hypothesis that edaravone, approved in Japan as aFigure 5 Immunoblotting with anti-iNOS 24hours (1day) after reperfu
iNOS expression.neuro-protective agent, could protect skeletal muscles
from I/R injury not only in the animal model, but also in
clinical situations. Furthermore, it has been reported that
application of other antioxidants has therapeutic potential
for I/R injury of skeletal muscle. The present study dem-
onstrates that pretreatment of edaravone significantly pro-
tects against I/R injury of skeletal muscles in the hindlimb
of mice. This study is particularly significant for showing
the therapeutic benefits of a single-dose administration of
edaravone 30 minutes prior to the onset of ischemia. This
preischemic treatment protocol mimics the commonly
seen clinical conditions of long duration tourniquet use
for extremity surgery and plastic surgeries such as free
muscle transfer.sion. Pretreatment of edaravone decreased the level of
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scavenging free radicals with edaravone. The final com-
mon pathway of I/R injury is edema, attraction of activated
leukocytes, and the formation of membrane-attack com-
plexes, all of which lead to disruption of cell membranes
resulting cell death [17]. The oxygen free radicals initiate
lipid peroxidation of cell membranes, which causes cellular
dysfunction and tissue necrosis. Our results showed that
one dose of pretreatment edaravone efficiently reduced
lipid peroxidation and neutrophil infiltration into the is-
chemic muscles. Therefore, the scavenging of oxygen free
radicals induced immediately after ischemia-reperfusion
may not only maintain tissue viability but also enable suffi-
cient contractile function of skeletal muscle.
Furthermore, expression of iNOS, which was shown to
play an important role in the pathophysiology of I/R injury
in other organs as well as inflammatory cytokine, was
inhibited in the skeletal muscles treated by edaravone
[20,42]. The skeletal muscles were also reported to be
influenced by NO generated by inducible form of NOS
[43]. Barker et al. demonstrated that the area of necrosis
was greater in wild-type than in iNOS-knockout mice, the
difference being significant after 90 minutes of ischemia
[43]. NO is formed as a metabolic product the stepwise
conversion of L-arginine guanidine nitrogen atoms [44].
The presence of an unpaired electron in the NO radical
makes it highly reactive, with a half-life of only a few se-
conds and readily capable of reacting with other species
such as superoxides. The reaction is catalyzed by the NOS
enzyme, of which three isoforms have been identified,
each having specific localizations and functions [29].
Three NOS isoforms has been characterized, each enco-
ded by different chromosomes. Two enzyme isoforms are
constitutively expressed (endothelial eNOS and neuronal
nNOS), whereas one isoform is an inducible enzyme
(iNOS), initially found in macrophages. iNOS levels are
markedly increased in inflammatory conditions, such as
autoimmune inflammatory myopathies. The inducible iso-
form of NOS becomes up regulated in response to inflam-
matory stimuli such as endotoxins, cytokines and lipid
mediators. Surges in NO production mediated by iNOS
are cytotoxic and have been implicated in the inflamma-
tory destruction of tissues such as heart, kidney, liver,
brain, intestine and skeletal muscle [45]. In our experi-
ments expression of iNOS was inhibited in the skeletal
muscles treated by edaravone. Therefore, directly inhibi-
ting lipid peroxidation of the myocyte by free radicals in
skeletal muscles may reduce the secondary edema and
inflammatory infiltration incidence of oxidative stress on
tissues.
Conclusion
The injury severity score in the I/R + Ed group com-
pared to the I/R group showed a significantly a lowerrate both in GC and TA samples. While edaravone may
have multiple effects, our data showed that pretreatment
with edaravone protected muscle tissue from damage
due to ischemia-reperfusion. We speculate that pretreat-
ment of edaravone directly inhibits lipid peroxidation of
myocytes by free radicals in skeletal muscles after I/R in-
jury and indirectly protects myocytes from secondary
damage due to edema, inflammatory infiltration and
transduction of oxidative stress. Further studies are
warranted to confirm the novel therapeutic potential
edaravone may have for I/R injuries of skeletal muscle.
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